APA (7th ed.) Citation

Oya, J., Shimizu, M., Kubota, R., Suda, R., & Nagkagami, T. (2025). Effectiveness for adding or switching from other incretin‐related drugs to oral semaglutide in type 2 diabetes. Journal of Diabetes Investigation, 16(4), 608. https://doi.org/10.1111/jdi.14391

Chicago Style (17th ed.) Citation

Oya, Junko, Mika Shimizu, Ryo Kubota, Rika Suda, and Tomoko Nagkagami. "Effectiveness for Adding or Switching from Other Incretin‐related Drugs to Oral Semaglutide in Type 2 Diabetes." Journal of Diabetes Investigation 16, no. 4 (2025): 608. https://doi.org/10.1111/jdi.14391.

MLA (9th ed.) Citation

Oya, Junko, et al. "Effectiveness for Adding or Switching from Other Incretin‐related Drugs to Oral Semaglutide in Type 2 Diabetes." Journal of Diabetes Investigation, vol. 16, no. 4, 2025, p. 608, https://doi.org/10.1111/jdi.14391.